Informace o publikaci
Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors
| Autoři | |
|---|---|
| Rok publikování | 2012 |
| Druh | Článek v odborném periodiku |
| Časopis / Zdroj | Haemophilia |
| Fakulta / Pracoviště MU | |
| Citace | |
| Doi | http://dx.doi.org/10.1111/j.1365-2516.2012.02920.x |
| Obor | Onkologie a hematologie |
| Klíčová slova | bleeding disorders; inhibitor |
| Popis | Haemophilia registries, such as HemoRec, provide a valuable source of real-world data for the study of treatment modalities. We have reported that early treatment with rFVIIa appeared more effective than delayed-onset treatment in controlling the incidence of re-bleeding. The current study investigated whether time to treatment and/or initial dose of rFVIIa affects bleeding duration and, for the first time, their impact on acute pain control in inhibitor patients. |